Reginster JY, Gillet P, Gosset C. Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: Need for a concerted public health strategy. Bull World Health Organ. 2001;79:942–6.
Nelson SB, Pinkney JA, Chen AF, Tande AJ. Executive summary: Periprosthetic joint infection—Current clinical challenges. Clin Infect Dis. 2023;77:939–40. DOI:https://doi.org/10.1093/cid/ciad457.
Beam E, Osmon D. Prosthetic joint infection update. Infect Dis Clin North Am. 2018;32:843–59. DOI:https://doi.org/10.1016/j.idc.2018.06.005.
Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195–283. DOI:https://doi.org/10.2146/ajhp120568.
Tsaras G, Osmon DR, Mabry T, Lahr B, St Sauveur J, Yawn B, et al. Incidence, secular trends, and outcomes of prosthetic joint infection: A population-based study, Olmsted county, Minnesota, 1969-2007. Infect Control Hosp Epidemiol. 2012;33:1207–12. DOI:https://doi.org/10.1086/668421.
Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br. 2005;87:844–50. DOI:https://doi.org/10.1302/0301-620X.87B6.15121.
Kong L, Cao J, Zhang Y, Ding W, Shen Y. Risk factors for periprosthetic joint infection following primary total hip or knee arthroplasty: A meta-analysis. Int Wound J. 2017;14:529–36. DOI:https://doi.org/10.1111/iwj.12640.
Triantafyllopoulos GK, Soranoglou VG, Memtsoudis SG, Sculco TP, Poultsides LA. Rate and risk factors for periprosthetic joint infection among 36,494 primary total hip arthroplasties. J Arthroplasty. 2018;33:1166–70. DOI:https://doi.org/10.1016/j.arth.2017.11.040.
Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD, INFORM Team. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: A systematic review and meta-analysis. PLoS One. 2016;11:e0150866. DOI:https://doi.org/10.1371/journal.pone.0150866.
Wolff DT, Shah NV, Eldib AM, Shah AT, Panchal AJ, Krasnyanskiy B, et al. Differences in infection rates by surgical approach in total hip arthroplasty and patient sex: A systematic review. Iowa Orthop J. 2022;42:60–5.
Weinstein EJ, Stephens-Shields AJ, Newcomb CW, Silibovsky R, Nelson CL, O’Donnell JA, et al. Incidence, microbiological studies, and factors associated with prosthetic joint infection after total knee arthroplasty. JAMA Netw Open. 2023;6:e2340457. DOI:https://doi.org/10.1001/jamanetworkopen.2023.40457.
Liukkonen RJ, Honkanen M, Reito AP, Skyttä ET, Karppelin M, Eskelinen AP. Trends in revision hip arthroplasty for prosthetic joint infection: A single-center study of 423 hips at a high-volume center between 2008 and 2021. J Arthroplasty. 2023;38:1151–9. DOI:https://doi.org/10.1016/j.arth.2023.02.061.
Fraval A, Hozack WJ. Managing the patient with peripheral vascular disease before total knee arthroplasty surgery. Orthop Clin North Am. 2023;54:259–67. DOI:https://doi.org/10.1016/j.ocl.2023.02.011.
Yeganeh MH, Kheir MM, Shahi A, Parvizi J. Rheumatoid arthritis, disease modifying agents, and periprosthetic joint infection: What does a joint surgeon need to know? J Arthroplasty. 2018;33:1258–64. DOI:https://doi.org/10.1016/j.arth.2017.11.031.
Tojo KJ, Ohtori A. Pharmacokinetic model of intravitreal drug injection. Math Biosci. 1994;123:59–75. DOI:https://doi.org/10.1016/0025-5564(94)90018-3.
Ritter C, Paddle B. Testosterone and hydrocortisone-stimulated responses of reduced pyridine nucleotide fluorescence in prostates cultured from castrate rats. Biochim Biophys Acta. 1967;143:547–53. DOI:https://doi.org/10.1016/0005-2728(67)90059-x.
Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet. 2016;387:386–94. DOI:https://doi.org/10.1016/S0140-6736(14)61798-0.
Azarkane M, Boussakri H, Shimi M, Elibrahimi A, Elmrini A. Les complications tardives de prothèse totale de la hanche: À propos de 42 cas [Late complications of total hip prosthesis: Apropos of 42 cases]. Pan Afr Med J. 2013;14:17. DOI:https://doi.org/10.11604/pamj.2013.14.17.2265.
Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am. 1998;80:961–8. DOI:https://doi.org/10.2106/00004623-199807000-00004.
